Skip to main content

News

HHS Nominee Tom Price Targeted Panel That Urged Fewer Cancer Screenings

By ProPublica  
   February 01, 2017

Regardless of what happens politically, she said, patients and doctors will still need evidence-based recommendations to make informed decisions.

The evidence-based work of the task force could be "endangered" because the panel is caught up in the political fight around the ACA, said Dr. Sheldon Greenfield executive co-director of the Health Policy Research Institute at the University of California, Irvine. "It wouldn't surprise me if it does become a casualty."

The worst outcome, he said, would be for health care in the United States to revert to the way it used to be. The old joke is that doctors ignore science and say, "I know best," Greenfield said, trumping evidence-based medicine with "eminence-based" medicine. 

Marshall Allen is examining how waste and overtreatment are affecting patients and raising the cost of care. If you have evidence of wasted health-care dollars, please email him at marshall.allen@propublica.org.

ProPublica is an independent, non-profit newsroom that produces investigative journalism in the public interest.


Get the latest on healthcare leadership in your inbox.